Journal article
Genetic screening for Niemann-Pick disease type C in adults with neurological and psychiatric symptoms: Findings from the ZOOM study
P Bauer, DJ Balding, HH Klünemann, DEJ Linden, DS Ory, M Pineda, J Priller, F Sedel, A Muller, H Chadha-Boreham, RWD Welford, DS Strasser, MC Patterson
Human Molecular Genetics | Published : 2013
DOI: 10.1093/hmg/ddt284
Abstract
Niemann-Pick disease type C (NP-C) is a rare, autosomal-recessive, progressive neurological disease caused by mutations in either theNPC1gene (in95%of cases) or theNPC2gene. This observational, multicentre genetic screening study evaluated the frequency and phenotypes of NP-C in consecutive adult patients with neurological and psychiatric symptoms. Diagnostic testing for NP-C involved NPC1 and NPC2 exonic gene sequencing and gene dosage analysis. When available, results of filipin staining, plasma cholestane-3β, 5α, 6β-triol assays and measurements of relevant sphingolipids were also collected. NPC1 and NPC2 gene sequencing was completed in 250/256 patients from 30 psychiatric and neurologic..
View full abstractGrants
Funding Acknowledgements
This study was sponsored by Actelion Pharmaceuticals Ltd. Funding to pay the Open Access publication charges for this article was provided by Actelion Pharmaceuticals Ltd.